BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28407149)

  • 1. Determination of the Biological Form of Human Cytomegalovirus DNA in the Plasma of Solid-Organ Transplant Recipients.
    Tong Y; Pang XL; Mabilangan C; Preiksaitis JK
    J Infect Dis; 2017 Apr; 215(7):1094-1101. PubMed ID: 28407149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole blood real-time quantitative PCR for cytomegalovirus infection follow-up in transplant recipients.
    Garrigue I; Boucher S; Couzi L; Caumont A; Dromer C; Neau-Cransac M; Tabrizi R; Schrive MH; Fleury H; Lafon ME
    J Clin Virol; 2006 May; 36(1):72-5. PubMed ID: 16481215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus sequence variability, amplicon length, and DNase-sensitive non-encapsidated genomes are obstacles to standardization and commutability of plasma viral load results.
    Naegele K; Lautenschlager I; Gosert R; Loginov R; Bir K; Helanterä I; Schaub S; Khanna N; Hirsch HH
    J Clin Virol; 2018 Jul; 104():39-47. PubMed ID: 29727833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation of cytomegalovirus positivity in the peripheral blood samples of risky patients by shell-vial cell culture, antigenemia test and real-time polymerase chain reaction].
    Gökahmetoğlu S; Yağmur G; Mutlu Sarıgüzel F; Deniz E
    Mikrobiyol Bul; 2011 Apr; 45(2):288-95. PubMed ID: 21644072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of CMV load in solid organ transplant recipients by pp65 antigenemia and real-time quantitative DNA PCR assay: correlation with pp67 RNA detection.
    Mengoli C; Cusinato R; Biasolo MA; Cesaro S; Parolin C; Palù G
    J Med Virol; 2004 Sep; 74(1):78-84. PubMed ID: 15258972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination, validation and standardization of a CMV DNA cut-off value in plasma for preemptive treatment of CMV infection in solid organ transplant recipients at lower risk for CMV infection.
    Martín-Gandul C; Pérez-Romero P; Sánchez M; Bernal G; Suárez G; Sobrino M; Merino L; Cisneros JM; Cordero E;
    J Clin Virol; 2013 Jan; 56(1):13-8. PubMed ID: 23131346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus (CMV) DNA load in plasma for the diagnosis of CMV disease before engraftment in hematopoietic stem-cell transplant recipients.
    Limaye AP; Huang ML; Leisenring W; Stensland L; Corey L; Boeckh M
    J Infect Dis; 2001 Feb; 183(3):377-82. PubMed ID: 11133368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value.
    Martín-Dávila P; Fortún J; Gutiérrez C; Martí-Belda P; Candelas A; Honrubia A; Barcena R; Martínez A; Puente A; de Vicente E; Moreno S
    J Clin Virol; 2005 Jun; 33(2):138-44. PubMed ID: 15911429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous quantification of Epstein-Barr virus, cytomegalovirus, and human herpesvirus 6 DNA in samples from transplant recipients by multiplex real-time PCR assay.
    Wada K; Kubota N; Ito Y; Yagasaki H; Kato K; Yoshikawa T; Ono Y; Ando H; Fujimoto Y; Kiuchi T; Kojima S; Nishiyama Y; Kimura H
    J Clin Microbiol; 2007 May; 45(5):1426-32. PubMed ID: 17376882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CMV antigenemia and quantitative viral load assessments in hematopoietic stem cell transplant recipients.
    Cardeñoso L; Pinsky BA; Lautenschlager I; Aslam S; Cobb B; Vilchez RA; Hirsch HH
    J Clin Virol; 2013 Feb; 56(2):108-12. PubMed ID: 23146665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cytomegalovirus viral load measure by real-time PCR with pp65 antigenemia for the diagnosis of cytomegalovirus disease in solid organ transplant patients.
    Hernando S; Folgueira L; Lumbreras C; San Juan R; Maldonado S; Prieto C; Babiano MJ; Delgado J; Andres A; Moreno E; Aguado JM; Otero JR
    Transplant Proc; 2005 Nov; 37(9):4094-6. PubMed ID: 16386635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of cytomegalovirus DNA by a fully automated real-time PCR for early diagnosis and monitoring of active viral infection in solid organ transplant recipients.
    Boaretti M; Sorrentino A; Zantedeschi C; Forni A; Boschiero L; Fontana R
    J Clin Virol; 2013 Feb; 56(2):124-8. PubMed ID: 23182772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of cytomegalovirus DNA by real-time polymerase chain reaction in peripheral blood specimens of patients with solid organ transplants: comparison with end-point PCR and pp65 antigen test.
    Allice T; Enrietto M; Pittaluga F; Varetto S; Franchello A; Marchiaro G; Ghisetti V
    J Med Virol; 2006 Jul; 78(7):915-22. PubMed ID: 16721848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus (CMV) DNA load predicts relapsing CMV infection after solid organ transplantation.
    Sia IG; Wilson JA; Groettum CM; Espy MJ; Smith TF; Paya CV
    J Infect Dis; 2000 Feb; 181(2):717-20. PubMed ID: 10669361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of storage time on Cytomegalovirus DNA stability in plasma determined by quantitative real-time PCR.
    Xie L; Liang XN; Deng Y; Wang J; He Y; Li TJ; Huang S; Qin X; Li S
    J Virol Methods; 2014 Oct; 207():196-9. PubMed ID: 25019168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of real-time polymerase chain reaction and antigenemia assay to detect cytomegalovirus in pediatric transplants].
    Farfán U MJ; Torres T JP; Vergara A A; Donoso W G; Alba G A; Paris D C; Santolaya De P ME
    Rev Chilena Infectol; 2011 Apr; 28(2):113-7. PubMed ID: 21720689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are We There Yet? Impact of the First International Standard for Cytomegalovirus DNA on the Harmonization of Results Reported on Plasma Samples.
    Preiksaitis JK; Hayden RT; Tong Y; Pang XL; Fryer JF; Heath AB; Cook L; Petrich AK; Yu B; Caliendo AM
    Clin Infect Dis; 2016 Sep; 63(5):583-9. PubMed ID: 27307504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay, the amplicor CMV test, and a semi-quantitative polymerase chain reaction test after allogeneic marrow transplantation.
    Ksouri H; Eljed H; Greco A; Lakhal A; Torjman L; Abdelkefi A; Ben Othmen T; Ladeb S; Slim A; Zouari B; Abdeladhim A; Ben Hassen A
    Transpl Infect Dis; 2007 Mar; 9(1):16-21. PubMed ID: 17313466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and pharmacokinetics of a cytomegalovirus (CMV) DNA plasmid in human plasma during a clinical trial of an intramuscular CMV vaccine in hematopoietic stem cell transplant recipients.
    Salimnia H; Fairfax MR; Chandrasekar PH
    Transpl Infect Dis; 2014 Dec; 16(6):914-8. PubMed ID: 25412866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous monitoring of CMV and BKV by quantitative PCR in renal transplant recipients.
    Wu CZ; Chen XQ; Wang ZY; Pan XD; Bai YH; Yang YR; Zheng SL; Xia P
    J Virol Methods; 2014 Dec; 210():40-4. PubMed ID: 25261811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.